To use all functions of this page, please activate cookies in your browser.
With an accout for my.chemeurope.com you can always see everything at a glance – and you can configure your own website and individual newsletter.
- My watch list
- My saved searches
- My saved topics
- My newsletter
Biocon is India's leading biotechnology enterprise. Established in 1978, the company today is an integrated biotechnology enterprise focused on the development of biopharmaceuticals. The company serves partners and customers in over 50 countries. Within the biotechnology space, the company ranks first in Asia in terms of revenues and market capitalisation and sixteenth globally.
The company is headed by Kiran Mazumdar-Shaw, India's second richest woman (after Sudha Gopalakrishnan, wife of Kris Gopalakrishnan, CEO and MD Infosys). She achieved this status after Biocon went for an IPO in 2004. Biocon became only the second Indian company to cross a market capitalisation of one billion U.S. $ on the first day of listing. Mazumdar-Shaw and her husband John Shaw own over 60% of the company's stock.
Additional recommended knowledge
|This article is licensed under the GNU Free Documentation License. It uses material from the Wikipedia article "Biocon". A list of authors is available in Wikipedia.|